Form 4 for EW Edwards Lifesciences
Accepted 2023-09-05 00:00:00 ET · period of report 2023-09-05 · accession 0001225208-23-008709 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-05 | 2023-09-05 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 33.8K | +654% | +$1.08M |
| D | 2023-09-05 | 2023-09-05 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $75.86 | -29.4K | 4,486 | -87% | -$2.23M |
| D | 2023-09-05 | 2023-09-05 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $0.00 | -29.4K | 234.8K | -11% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-05 | M | A | 29,350 | $36.75 | 33,835.82 | D | — | — | |
| 2 | Common | Common Stock | 2023-09-05 | S | D | 29,350 | $75.86 | 4,485.82 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $75.40 to $76.24. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Derivative | Employee Stock Option (Right to Acquire) | 2023-09-05 | M | D | 29,350 | $0.00 | 234,800 | D | $36.75 · 2017-06-11 to 2024-05-10 | 29,350 Common Stock |